Literature DB >> 2527643

Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans.

D A Cox1, J A Vita, C B Treasure, R D Fish, R W Alexander, P Ganz, A P Selwyn.   

Abstract

Studies in animals have suggested that increases in blood flow result in dilation of large arteries by an endothelium-dependent mechanism. Atherosclerosis can impair endothelium-dependent vasodilation to vasoactive agents. The purpose of this study was to determine whether or not large coronary arteries in humans exhibit dilation with increases in blood flow and to test the hypothesis that this response is impaired in the presence of atherosclerosis. Graded concentrations of adenosine were infused into the distal left anterior descending (LAD) coronary artery to test the dilator response of the proximal LAD to increases in blood flow. The proximal LAD was thereby exposed to changes in blood flow, but not directly to adenosine. Ten patients with angiographically smooth proximal LAD segments (group 1) and seven patients with irregularities in the proximal LAD consistent with mild atherosclerosis (group 2) were studied. Infusions of adenosine throughout the range of 0.022 to 2.2 mg/min into the LAD produced a dose-dependent increase in estimated coronary blood flow and a mean increase of 305 +/- 27% at 2.2 mg/min adenosine. At 2.2 mg/min adenosine, a striking difference (p less than 0.001) occurred between the significant flow-mediated dilation of the proximal LAD observed in group 1 (+13.2 +/- 1.3% from 2.63 +/- 0.16 mm, p less than 0.001), and the lack of dilation in group 2 (+1.8 +/- 1.5% from 3.20 +/- 0.17 mm, p = NS), despite a greater increase in coronary blood flow in group 2 (+387 +/- 29%) than in group 1 (+230 +/- 36%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527643     DOI: 10.1161/01.cir.80.3.458

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  64 in total

1.  The role of myocardial perfusion imaging in vascular endothelial dysfunction.

Authors:  V Dilsizian
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

Review 2.  Invasive assessment of the coronary circulation: intravascular ultrasound and Doppler.

Authors:  David E Newby; Keith A A Fox
Journal:  Br J Clin Pharmacol       Date:  2002-06       Impact factor: 4.335

Review 3.  St Cyres lecture. Endothelium in control.

Authors:  A H Henderson
Journal:  Br Heart J       Date:  1991-03

Review 4.  Coronary physiology assessment in the catheterization laboratory.

Authors:  Felipe Díez-Delhoyo; Enrique Gutiérrez-Ibañes; Gerard Loughlin; Ricardo Sanz-Ruiz; María Eugenia Vázquez-Álvarez; Fernando Sarnago-Cebada; Rocío Angulo-Llanos; Ana Casado-Plasencia; Jaime Elízaga; Francisco Fernández Avilés Diáz
Journal:  World J Cardiol       Date:  2015-09-26

Review 5.  Metabolic syndrome and endothelial dysfunction.

Authors:  Alessia Fornoni; Leopoldo Raij
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

Review 6.  Obstructive sleep apnoea.

Authors:  Sophie D West; Chris Turnbull
Journal:  Eye (Lond)       Date:  2018-02-02       Impact factor: 3.775

Review 7.  Vascular and Endothelial Function in Youth with Type 2 Diabetes Mellitus.

Authors:  Amy S Shah; Elaine M Urbina
Journal:  Curr Diab Rep       Date:  2017-06       Impact factor: 4.810

Review 8.  Arterial stiffness as a risk factor for coronary atherosclerosis.

Authors:  Daniel A Duprez; Jay N Cohn
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.113

9.  Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility.

Authors:  K E Sorensen; D S Celermajer; D J Spiegelhalter; D Georgakopoulos; J Robinson; O Thomas; J E Deanfield
Journal:  Br Heart J       Date:  1995-09

10.  Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.

Authors:  A A Quyyumi; N Dakak; N P Andrews; S Husain; S Arora; D M Gilligan; J A Panza; R O Cannon
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.